Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS)
CNY 19.6
(0.56%)
CNY 19.6
(0.56%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 784.34 Million CNY | -5.39% |
| 2022 | 829.07 Million CNY | 8.07% |
| 2021 | 767.13 Million CNY | 20.61% |
| 2020 | 636.05 Million CNY | 16.33% |
| 2019 | 546.75 Million CNY | 6.9% |
| 2018 | 511.45 Million CNY | 38.24% |
| 2017 | 369.96 Million CNY | 17.49% |
| 2016 | 314.87 Million CNY | 4.3% |
| 2015 | 301.91 Million CNY | 0.11% |
| 2014 | 301.59 Million CNY | 19.19% |
| 2013 | 253.03 Million CNY | 42.35% |
| 2012 | 177.75 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 130.52 Million CNY | -40.91% |
| 2024 Q1 | 220.9 Million CNY | -8.61% |
| 2024 Q3 | 119.45 Million CNY | -8.49% |
| 2023 Q4 | 241.71 Million CNY | 41.24% |
| 2023 Q3 | 171.14 Million CNY | 3.51% |
| 2023 FY | 784.34 Million CNY | -5.39% |
| 2023 Q1 | 206.15 Million CNY | -35.86% |
| 2023 Q2 | 165.33 Million CNY | -19.8% |
| 2022 Q4 | 321.42 Million CNY | 103.29% |
| 2022 Q2 | 145.8 Million CNY | -28.43% |
| 2022 Q1 | 203.72 Million CNY | -29.12% |
| 2022 FY | 829.07 Million CNY | 8.07% |
| 2022 Q3 | 158.11 Million CNY | 8.44% |
| 2021 Q3 | 162.24 Million CNY | 13.17% |
| 2021 Q4 | 287.39 Million CNY | 77.14% |
| 2021 Q1 | 174.13 Million CNY | -28.05% |
| 2021 Q2 | 143.36 Million CNY | -17.67% |
| 2021 FY | 767.13 Million CNY | 20.61% |
| 2020 Q2 | 103.42 Million CNY | -22.12% |
| 2020 Q3 | 157.82 Million CNY | 52.61% |
| 2020 FY | 636.05 Million CNY | 16.33% |
| 2020 Q4 | 242 Million CNY | 53.33% |
| 2020 Q1 | 132.8 Million CNY | -34.6% |
| 2019 Q3 | 89.21 Million CNY | 0.24% |
| 2019 FY | 546.75 Million CNY | 6.9% |
| 2019 Q4 | 203.06 Million CNY | 127.6% |
| 2019 Q2 | 89 Million CNY | -46.21% |
| 2019 Q1 | 165.46 Million CNY | -11.57% |
| 2018 Q1 | 126.51 Million CNY | -7.26% |
| 2018 FY | 511.45 Million CNY | 38.24% |
| 2018 Q4 | 187.1 Million CNY | 92.17% |
| 2018 Q3 | 97.36 Million CNY | -3.08% |
| 2018 Q2 | 100.46 Million CNY | -20.59% |
| 2017 FY | 369.96 Million CNY | 17.49% |
| 2017 Q1 | 87.48 Million CNY | -19.34% |
| 2017 Q2 | 79.54 Million CNY | -9.08% |
| 2017 Q3 | 66.51 Million CNY | -16.37% |
| 2017 Q4 | 136.41 Million CNY | 105.08% |
| 2016 Q1 | 84.93 Million CNY | 0.0% |
| 2016 Q4 | 108.46 Million CNY | 88.42% |
| 2016 FY | 314.87 Million CNY | 4.3% |
| 2016 Q3 | 57.56 Million CNY | -9.91% |
| 2016 Q2 | 63.9 Million CNY | -24.77% |
| 2015 FY | 301.91 Million CNY | 0.11% |
| 2014 FY | 301.59 Million CNY | 19.19% |
| 2013 FY | 253.03 Million CNY | 42.35% |
| 2012 FY | 177.75 Million CNY | 0.0% |